# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-070835
Filing Date
2025-07-25
Accepted
2025-07-25 16:18:29
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | tm2521674d3_defa14a.htm | DEFA14A | 12214
2 | GRAPHIC | tm2521674d3_defa14aimg001.jpg | GRAPHIC | 378218
3 | GRAPHIC | tm2521674d3_defa14aimg002.jpg | GRAPHIC | 347414
| Complete submission text file | 0001104659-25-070835.txt |  | 1012831

Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

EIN.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEFA14A | Act: 34 | File No.: 001-38596 | Film No.: 251151918
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)